- |||||||||| Trial completion: BADS: Behavior and Driving Safety Study (clinicaltrials.gov) - Jan 5, 2019
P=N/A, N=864, Completed, N=580 --> 222 | Trial completion date: Jun 2019 --> Oct 2018 | Not yet recruiting --> Terminated | Trial primary completion date: Jun 2019 --> Oct 2018; The number of participants included and especially who connected to the application (less than 50% of the target) does not meet the objective set by the study. Active, not recruiting --> Completed
- |||||||||| Trial completion date, Trial primary completion date: BADS: Behavior and Driving Safety Study (clinicaltrials.gov) - Feb 13, 2018
P=N/A, N=800, Active, not recruiting, Active, not recruiting --> Completed Trial primary completion date: Jan 2018 --> Dec 2018 | Trial completion date: Jan 2018 --> Dec 2018
- |||||||||| Trial completion, Enrollment change, Trial primary completion date: Behavior and Driving Safety Study II (clinicaltrials.gov) - Jul 11, 2017
P=N/A, N=200, Completed, Trial primary completion date: Jan 2018 --> Dec 2018 | Trial completion date: Jan 2018 --> Dec 2018 Active, not recruiting --> Completed | N=100 --> 200 | Trial primary completion date: Dec 2013 --> Dec 2015
- |||||||||| Trial primary completion date: BADS: Behavior and Driving Safety Study (clinicaltrials.gov) - Jun 27, 2017
P=N/A, N=800, Active, not recruiting, Active, not recruiting --> Completed | N=100 --> 200 | Trial primary completion date: Dec 2013 --> Dec 2015 Trial primary completion date: Dec 2013 --> Jan 2018
- |||||||||| Trial completion, Enrollment change, Trial primary completion date: Ghrelin for Alcohol Use in Non-Treatment-Seeking Heavy Drinkers (clinicaltrials.gov) - Jun 15, 2017
P2, N=18, Completed, Trial primary completion date: Dec 2013 --> Jan 2018 Recruiting --> Completed | N=124 --> 18 | Trial primary completion date: Sep 2020 --> Jun 2017
- |||||||||| Trial completion: Acute and Residual Effects of Caffeinated Beer (clinicaltrials.gov) - Jul 24, 2016
P2, N=144, Completed, Recruiting --> Completed | N=124 --> 18 | Trial primary completion date: Sep 2020 --> Jun 2017 Recruiting --> Completed
- |||||||||| topiramate / Generic mfg.
Enrollment change, Trial termination, Trial primary completion date: Topiramate to Reduce Heavy Drinking in HIV-Positive Heavy Drinkers (clinicaltrials.gov) - Feb 18, 2016 P2, N=4, Terminated, Recruiting --> Completed N=60 --> 4 | Active, not recruiting --> Terminated | Trial primary completion date: Jun 2014 --> Jan 2014; We terminated the study due to problems recruiting alcoholic subjects with HIV.
- |||||||||| zonisamide / Generic mfg.
Enrollment change, Trial termination: Zonisamide for Heavy Drinkers With Bipolar Disorder (clinicaltrials.gov) - Jan 7, 2016 P2, N=3, Terminated, N=60 --> 4 | Active, not recruiting --> Terminated | Trial primary completion date: Jun 2014 --> Jan 2014; We terminated the study due to problems recruiting alcoholic subjects with HIV. N=40 --> 3 | Recruiting --> Terminated; recruitment infeasible
- |||||||||| zonisamide / Generic mfg., levetiracetam / Generic mfg., topiramate / Generic mfg.
Enrollment change, Trial termination, Trial primary completion date: Interdisciplinary Study of Two Novel Anticonvulsants in Alcoholism (clinicaltrials.gov) - Apr 7, 2015 P2, N=85, Terminated, Recruiting --> Completed | Trial primary completion date: Aug 2014 --> Nov 2014 N=160 --> 85 | Active, not recruiting --> Terminated | Trial primary completion date: Mar 2014 --> Aug 2013; Recruitment goals could not be met before ending of funding for this project.
- |||||||||| quetiapine / Generic mfg.
Trial completion, Trial primary completion date: Seroquel for Frequent, Heavy Drinkers (clinicaltrials.gov) - Sep 19, 2014 P2, N=156, Completed, N=160 --> 85 | Active, not recruiting --> Terminated | Trial primary completion date: Mar 2014 --> Aug 2013; Recruitment goals could not be met before ending of funding for this project. Active, not recruiting --> Completed | Trial primary completion date: Jul 2012 --> Jan 2013
- |||||||||| Trial completion, Phase classification: Motivational Interviews for Incarcerated Teens - 1 (clinicaltrials.gov) - Aug 19, 2014
P=N/A, N=200, Completed, Active, not recruiting --> Completed | Trial primary completion date: Jul 2012 --> Jan 2013 Recruiting --> Completed | Phase classification: P2 --> PN/A
- |||||||||| Enrollment closed: Behavior and Driving Safety Study II (clinicaltrials.gov) - Oct 26, 2012
P=N/A, N=100, Active, not recruiting, Active, not recruiting --> Completed Enrolling by invitation --> Active, not recruiting
- |||||||||| Enrollment closed: BADS: Behavior and Driving Safety Study (clinicaltrials.gov) - Oct 26, 2012
P=N/A, N=800, Active, not recruiting, Enrolling by invitation --> Active, not recruiting Enrolling by invitation --> Active, not recruiting
- |||||||||| Chantix (varenicline) / Pfizer
Trial completion: NCIG 003: Varenicline for Alcohol Dependence (clinicaltrials.gov) - Oct 15, 2012 P2, N=200, Completed, Enrolling by invitation --> Active, not recruiting Active, not recruiting --> Completed
- |||||||||| quetiapine / Generic mfg.
Enrollment closed: Seroquel for Frequent, Heavy Drinkers (clinicaltrials.gov) - Jul 4, 2012 P2, N=180, Active, not recruiting, Active, not recruiting --> Completed Recruiting --> Active, not recruiting
|